Slovenia's Salus sees 2020 net profit at 5.7 mln euro

Salus provided no comparative figures in a statement with the Ljubljana Stock Exchange.

It, however, said it plans an operating profit of 7.3 million euro and 11.2 million euro in earnings before interest, taxes, depreciation and amortisation (EBITDA) next year.

The company said earlier its net profit rose by an annual 38% to 5.4 million euro in the January-September period as net sales increased by more than 35% to 255 million euro.

Salus's operating profit increased by 62% on the year to 5.9 million euro in the January-September period, while EBITDA advanced 64% to 8.5 million euro.

Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.

($ = 0.9028 euro)